sciencebasedmedicine.org
Homeopathic industry and its acolytes make poor showing before FDA
Ask your pharmacist if nothing is right for you. (HT @leachkathleen) On April 21 and 22, the FDA held a public hearing: to obtain information and comments from stakeholders about the current use of human drug and biological products labeled as homeopathic, as well as the Agency's regulatory framework for such products. . . . FDA is seeking participants for the public hearing and written comments from all interested parties, including, but not limited to, consumers, patients, caregivers, health care professionals, patient groups, and industry. The FTC recently announced that it, too, is wading into the homeopathic waters. The FTC, which regulates advertising of homeopathic products, will hold a public workshop on September 21 in Washington, DC, "to examine advertising for over-the-counter (OTC) homeopathic products." Like the FDA, it will also accept public comments online. All of this regulatory buzz caused the FDA Law Blog to take notice. (The blog is hosted by a law firm specializing